Alnylam Pharmaceuticals (ALNY) Treasury Shares (2011 - 2025)

Alnylam Pharmaceuticals (ALNY) has 14 years of Treasury Shares data on file, last reported at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 0.64% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 0.64% YoY), and the FY2025 full-year result was $1.7 million, up 0.64% from the prior year.
• Treasury Shares for Q4 2025 stood at $1.7 million, up from $1.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.7 million in Q4 2025 and bottomed at $75000.0 in Q4 2021.
• The 5-year median for Treasury Shares is $1.0 million (2023), against an average of $972200.0.
• The widest annual swing landed in 2021, when Treasury Shares tumbled 92.81%; it then jumped 289.33% in 2022.
• A 5-year view of Treasury Shares shows it stood at $75000.0 in 2021, then surged by 289.33% to $292000.0 in 2022, then surged by 253.77% to $1.0 million in 2023, then surged by 66.99% to $1.7 million in 2024, then climbed by 0.64% to $1.7 million in 2025.
• The last three Treasury Shares figures came in at $1.7 million (Q4 2025), $1.7 million (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.

Peer Comparison